Gentel Biosciences last week launched a menu of new APiX Human Tumor Profiling Kits. The kits, which contain tissue-lysate protein arrays and chromogenic-based detection reagents, are suitable for the testing of putative protein biomarkers in over 13 cancer subtypes, according to the firm.
Gentel's kits combine its APiX chromogenic detection technology and Protein Biotechnologies' collection of normal and diseased human tissue for the study of protein expression differences in patient sample sets. Arrays are available to study human breast, colon, female reproductive tract, larynx and skin, liver, lung, prostate and testes, stomach, thyroid, ovary, kidney, bone marrow, and bladder tissues.
Each kit is configured for use with Gentel's Proteomics Multi-System and AthenaQuant analysis software.